Skip to main content
Figure 6 | Molecular Cancer

Figure 6

From: Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways

Figure 6

Sorafenib inhibits angiogenesis in CAM mode. A. Culture medium (n = 4). A1: 10× magnification, A2: 20× magnification; B. Osteosarcoma cell line conditioned medium (n = 6). B1:10× magnification, B2: 20× magnification; C. Conditioned medium of sorafenib treated cells (n = 5). C1:10× magnification, C2: 20× magnification; D. Osteosarcoma conditioned medium plus sorafenib 1 μM (n = 7). D1:10× magnification, D2: 20× magnification.

Back to article page

Molecular Cancer

ISSN: 1476-4598